JPMorgan Chase & Co. Increases Stock Position in Oscar Health, Inc. (NYSE:OSCR)

JPMorgan Chase & Co. raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 348.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 10,360,529 shares of the company’s stock after acquiring an additional 8,051,379 shares during the quarter. JPMorgan Chase & Co.’s holdings in Oscar Health were worth $139,246,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of OSCR. Vanguard Group Inc. raised its holdings in shares of Oscar Health by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock valued at $255,333,000 after purchasing an additional 586,626 shares during the last quarter. State Street Corp raised its stake in Oscar Health by 6.0% during the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after buying an additional 291,335 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after buying an additional 455,205 shares during the period. Hennessy Advisors Inc. boosted its stake in shares of Oscar Health by 550.3% in the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the last quarter. Finally, Glynn Capital Management LLC grew its holdings in shares of Oscar Health by 42.7% in the fourth quarter. Glynn Capital Management LLC now owns 2,733,237 shares of the company’s stock worth $36,735,000 after acquiring an additional 817,518 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Down 1.1 %

OSCR stock opened at $12.97 on Wednesday. The business’s 50-day moving average price is $14.79 and its 200-day moving average price is $15.94. The stock has a market cap of $3.25 billion, a P/E ratio of -648.28 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $12.43 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $20.21.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.